Prevention and treatment of vaginal stenosis resulting from pelvic radiation therapy

2006 ◽  
Vol 3 (10) ◽  
pp. 665-671 ◽  
Author(s):  
Judith K. Wolf
Keyword(s):  
Radiation Therapy ◽  
Pelvic Radiation ◽  
Vaginal Stenosis ◽  
Prevention And Treatment

scholarly journals Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer

2015 ◽  
Vol 92 (3) ◽  
pp. 548-554 ◽  
Author(s):  
Christina H. Son ◽  
Ethel Law ◽  
Jung Hun Oh ◽  
Aditya P. Apte ◽  
T. Jonathan Yang ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Anal Cancer ◽  
Pelvic Radiation ◽  
Vaginal Stenosis ◽  
Radiation Induced

The evolving role of pelvic radiation therapy

2003 ◽  
Vol 13 (2) ◽  
pp. 109-120 ◽  
Author(s):  
Terence Roberts ◽  
Mack Roach
Keyword(s):  
Radiation Therapy ◽  
Pelvic Radiation

Secondary cavernous hemangioma of urinary bladder following pelvic radiation therapy: a case report

2015 ◽  
Vol 36 (1) ◽  
pp. 112
Author(s):  
Jun-jie ZHAO ◽  
Bo YANG ◽  
Zhen-sheng ZHANG ◽  
Yang WANG ◽  
Ying-hao SUN ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Case Report ◽  
Urinary Bladder ◽  
Cavernous Hemangioma ◽  
Pelvic Radiation

scholarly journals From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 597
Author(s):  
Daniela Luvero ◽  
Salvatore Lopez ◽  
Giorgio Bogani ◽  
Francesco Raspagliesi ◽  
Roberto Angioli
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Risk Factor ◽  
Hpv Vaccine ◽  
Global Market ◽  
Cancer Death ◽  
Prevention Measures ◽  
Primary And Secondary Prevention ◽  
The World ◽  
Prevention And Treatment

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market: bivalent, quadrivalent, and nonavalent. The nonavalent vaccine provides protection against almost 90% of HPV-related CC. Despite availability of primary and secondary prevention measures, CC persists as one of the most common cancers among women around the world. Although CC is a largely preventable disease, management of persistent or recurrent CC no longer amenable to control with surgery or radiation therapy has not improved significantly with the progress of modern chemotherapy and disseminated carcinoma of the cervix remains a discouraging clinical entity with a 1-year survival rate between 10% and 15%. Over the last few years, there has been increasing interest in immunotherapy as a strategy to fight tumors. This article focuses on recent discoveries about the HPV vaccine and immunotherapies in the prevention and treatment of CC, highlighting the future view.

scholarly journals Comparison of surface matching and target matching for image-guided pelvic radiation therapy for both supine and prone patient positions

2016 ◽  
Vol 17 (3) ◽  
pp. 14-24 ◽  
Author(s):  
Hui Zhao ◽  
Brian Wang ◽  
Vikren Sarkar ◽  
Prema Rassiah-Szegedi ◽  
Y. Jessica Huang ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Surface Matching ◽  
Pelvic Radiation ◽  
Image Guided ◽  
Target Matching
Sign in / Sign up

Export Citation Format

Share Document